Search by Drug Name or NDC
NDC 63868-0485-01 Headache Relief 250; 250; 65 mg/1; mg/1; mg/1 Details
Headache Relief 250; 250; 65 mg/1; mg/1; mg/1
Headache Relief is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by CHAIN DRUG MARKETING ASSOCIATION INC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 63868-0485 |
|---|---|
| Product ID | 63868-485_7eee713e-7971-4c60-a606-6c7b00e07bcf |
| Associated GPIs | 64990003200350 |
| GCN Sequence Number | 040186 |
| GCN Sequence Number Description | aspirin/acetaminophen/caffeine TABLET 250-250-65 ORAL |
| HIC3 | H3D |
| HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
| GCN | 10414 |
| HICL Sequence Number | 001807 |
| HICL Sequence Number Description | ASPIRIN/ACETAMINOPHEN/CAFFEINE |
| Brand/Generic | Generic |
| Proprietary Name | Headache Relief |
| Proprietary Name Suffix | Extra Strength |
| Non-Proprietary Name | Acetaminophen, Aspirin and caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | CHAIN DRUG MARKETING ASSOCIATION INC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M013 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63868-0485-01 (63868048501)
| NDC Package Code | 63868-485-01 |
|---|---|
| Billing NDC | 63868048501 |
| Package | 1 BOTTLE, PLASTIC in 1 CARTON (63868-485-01) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 1992-11-17 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.06388 |
| Pricing Unit | EA |
| Effective Date | 2022-11-23 |
| NDC Description | QC HEADACHE RELIEF TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis